Use of LexA-based system to identify protein-protein interactions in vivo.
Daines
Dayle A
DA
Seattle Biomedical Research Institute, Seattle, Washington 98109, USA.
Granger-Schnarr
Michèle
M
Dimitrova
Maria
M
Silver
Richard P
RP
D000595:Amino Acid Sequence; D001426:Bacterial Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D001483:Base Sequence; D003001:Cloning, Molecular / Q000379:methods; D019281:Dimerization; D004926:Escherichia coli / Q000235:genetics* / Q000378:metabolism; D029968:Escherichia coli Proteins / Q000737:chemistry / Q000378:metabolism; D006193:Haemophilus influenzae / Q000235:genetics; D007202:Indicators and Reagents; D008969:Molecular Sequence Data; D016364:Reading Frames; D018741:Replication Origin; D012097:Repressor Proteins / Q000737:chemistry / Q000378:metabolism; D015183:Restriction Mapping / Q000379:methods; D012697:Serine Endopeptidases / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D000099160:LexA Repressor Protein
D001426:Bacterial Proteins; D029968:Escherichia coli Proteins; D007202:Indicators and Reagents; D012097:Repressor Proteins; D012697:Serine Endopeptidases; D000099160:LexA Repressor Protein